This inventor holds 2 USPTO granted patents. Top assignee: Nihon Nohyaku Co., Ltd.. Active years: 1995-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995-1996
Title: Yoshimitsu Matsui: Innovator in Pharmaceutical Chemistry
Introduction
Yoshimitsu Matsui is a notable inventor based in Kawachinagano, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications.
Latest Patents
Matsui holds 2 patents that focus on innovative chemical compounds. His latest patents include "Pyrimidine and pyridine derivatives, their production and use," which describes a compound that has an inhibitory effect on acyl-CoA:cholesterol O-acyltransferase (ACAT). This invention outlines a process for producing the compound and its various uses. Another significant patent is for "N-heteroaryl-N'-phenylurea derivatives, their production and use," which details a derivative useful as a prophylactic and therapeutic agent for hypercholesterolemia and atherosclerosis.
Career Highlights
Matsui is currently employed at Nihon Nohyaku Co., Ltd., where he continues to advance his research and development efforts in pharmaceutical innovations. His work has been instrumental in creating compounds that address critical health issues.
Collaborations
Throughout his career, Matsui has collaborated with esteemed colleagues such as Kenji Horiuchi and Masashi Nagamine. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Yoshimitsu Matsui's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to impact the development of therapeutic agents that address important health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile